Cytori
Therapeutics, Inc. (NASDAQ:CYTX) will present and provide a
corporate update from the 26th
Annual Roth Conference on Wednesday, March 12, at 10:30 AM PT.
The presentation will be webcast and may be accessed under “Webcasts”
under Cytori’s Investor Relations section of the website. The webcast
can be viewed live and will be available for replay after the
presentation on the Company's website.
About Cytori
Cytori Therapeutics, Inc. is developing cell therapies based on
autologous adipose-derived regenerative cells (ADRCs) to treat
cardiovascular disease and other medical conditions. Our scientific data
suggest ADRCs improve blood flow, moderate the inflammatory response and
keep tissue at risk of dying alive. As a result, we believe these cells
can be applied across multiple “ischemic” conditions. These therapies
are made available to the physician and patient at the point-of-care by
Cytori’s proprietary technologies and products, including the Celution®
system product family. www.cytori.com
Copyright Business Wire 2014